Results showed that the expression of NCAPH was significantly associated with tumor size (p = 0.032), depth of invasion (p = 0.029) and lymph node metastasis (p = 0.041), but not related to patients’ age, FIGO staging, tumor differentiation, or distant metastasis (Table 2), (Fig. 1F) (all p values > 0.05). The gene discussed is NCAPH; the disease is metastatic malignant neoplasm in the lymph nodes.